Business Wire

The Digital Cooperation Organization Hosted Its First Collaborative Roundtable With Social Media, Technology Companies, and Digital Platforms to Combat the Spread of Online Misinformation

28.8.2024 22:45:00 EEST | Business Wire | Press release

Share

The Digital Cooperation Organization (DCO), a global multilateral organization committed to enabling digital prosperity for all by accelerating the sustainable and inclusive growth of the digital economy, hosted a strategic roundtable discussion with major technology companies, and social media and digital platform representatives to address the societal impact of the spread of online misinformation.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240828374432/en/

Representatives from social media, technology companies, and digital platforms at the DCO HQ (Photo AETOSWire)

Building on the series of global roundtables conducted in 2023 as part of the “combating online misinformation” Digital Space Accelerators, this roundtable continuous the DCO’s ongoing efforts to combat online misinformation. Representatives from Google, LinkedIn, Meta and TikTok participated as key stakeholders to discuss this crucial issue affecting the digital world.

The roundtable, held at the DCO headquarters in Riyadh, Saudi Arabia, aimed to identify challenges and propose innovative solutions to foster trust and safeguard the digital economy. The participation of representatives from social media and digital platforms underscored the importance of the roundtable, providing a crucial platform for stakeholders to exchange perspectives and explore collaborative actions to combat online misinformation.

The discussions aimed to create an ongoing dialogue on the gravity of online misinformation as both a societal problem and a challenge to the digital economy. It also provided a platform for stakeholders to bridge their perspectives and work together to combat online misinformation, thereby ensuring a trustworthy digital information ecosystem.

"The exchange of ideas and insights from leading platforms has been invaluable. The key takeaway from the discussion was the importance of cooperation through a multistakeholder approach to combat online misinformation, which aligns with the DCO’s mission. We are confident that the outcomes of this roundtable will pave the way for a more informed and resilient digital society, and we look forward to our next collaborative roundtable to enable digital prosperity for all", said Alaa Abdulaal, Chief of the Digital Economy Foresight department at the Digital Cooperation Organization.

Sarah Al-Husseini, Head of Government Affairs & Public Policy, KSA at Google, said: People come to Google because they trust they will be able to find high quality information, which is why we take our commitment to combating misinformation through our products and our content policies very seriously. We work hard to retain that trust - designing our systems for quality and ensuring users are given access to a range of information from different voices and the tools to know what they can trust. We do not do it alone; in addition to continuously adapting our policies and technologies to prevent abuse, we openly share our technology and collaborate with experts to drive the industry forward and create a safer internet for everyone.

Ranim Alamin, Strategic Government Partnerships Head, KSA at LinkedIn, said: Taking part in the DCO's strategic roundtable offered us a valuable opportunity to discuss one of the more pressing issues in the digital world: Misinformation. The conversations we had with representatives from various leading platforms underscored the importance of a united approach to foster trust. We are committed to working together to build a more trusted and resilient digital information ecosystem.”

Tom Bonsundy-O'Bryan, Misinformation Policy, EMEA Lead at Meta, said: We were glad to attend this roundtable organized by the DCO and remain deeply committed to tackling misinformation - balancing our values of expression, safety, authenticity and privacy.”

Hatem Samman, Executive Director of Government Relations & Public Policy, KSA at TikTok, said: “At TikTok, we are committed to fostering a secure and trustworthy digital environment for the community. This roundtable provided an essential platform for discussing innovative strategies and collaborative actions to combat misinformation. By working together, we can create a safe, authentic space where people can discover content that is original and engage with people who are authentic.”

The Digital Cooperation Organization remains committed to fostering a collaborative approach to combating misinformation and ensuring the growth of the digital economy. The DCO looks forward to continuing this impactful work with its partners in the social media and digital platform space.

*Source: AETOSWire

View source version on businesswire.com: https://www.businesswire.com/news/home/20240828374432/en/

Contacts

Ahmed Bayouni
Media@dco.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye